RIVKAH COLEN to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications RIVKAH COLEN has written about Antineoplastic Agents, Immunological.
Connection Strength
0.494
-
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer. 2021 04; 9(4).
Score: 0.401
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.093